Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2003-1-16
pubmed:abstractText
Adjuvant chemotherapy has been suggested as a possible strategy to improve survival in women with early-stage ovarian cancer; however, all randomized studies to date have been too small to answer this question reliably.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0027-8874
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
95
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
105-12
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12529343-Aged, pubmed-meshheading:12529343-Antineoplastic Agents, pubmed-meshheading:12529343-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:12529343-Carboplatin, pubmed-meshheading:12529343-Carcinoma, pubmed-meshheading:12529343-Chemotherapy, Adjuvant, pubmed-meshheading:12529343-Cisplatin, pubmed-meshheading:12529343-Disease-Free Survival, pubmed-meshheading:12529343-Drug Administration Schedule, pubmed-meshheading:12529343-Female, pubmed-meshheading:12529343-Humans, pubmed-meshheading:12529343-International Cooperation, pubmed-meshheading:12529343-Middle Aged, pubmed-meshheading:12529343-Neoplasm Staging, pubmed-meshheading:12529343-Odds Ratio, pubmed-meshheading:12529343-Ovarian Neoplasms, pubmed-meshheading:12529343-Risk Factors, pubmed-meshheading:12529343-Survival Analysis, pubmed-meshheading:12529343-Treatment Outcome
pubmed:year
2003
pubmed:articleTitle
International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.
pubmed:affiliation
Department of Gynecology, Leiden University Medical Center, The Netherlands. J.B.M.Z.Trimbos@lumc.nl
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III